Immune architecture of oocyte competence: from development to senescence
- 1Center for Reproductive Medicine, The Affiliated Guangdong Second Provincial General Hospital of Jinan University
- 2Department of Immunology, University of Pittsburgh
- 3New York Fertility Center, New York-Prebyterian Healthcare System Affiliate Weill Cornell Medical College
Abstract
The mammalian oocyte does not develop in isolation. Throughout its protracted life history, from primordial germ cell specification to ovulation, the female gamete develops within a dynamic immune microenvironment that both supports and monitors its development. This review synthesizes current knowledge on the immunobiological mechanisms governing oocyte quality, with particular emphasis on how immune cells, cytokines, and inflammatory signaling pathways shape oocyte developmental competence across the reproductive lifespan. We examine the prenatal origins of ovarian immune colonization, the functional roles of tissue-resident macrophages, dendritic cells, and T lymphocytes in follicular dynamics, and the molecular pathways through which immune signals influence meiotic fidelity and mitochondrial function. The concept of the ovarian immune microenvironment as a critical determinant of oocyte quality is developed, integrating evidence from physiological ovarian aging and pathological conditions including primary premature ovarian insufficiency (POI). We further explore how immune checkpoint pathways, inflammasome activation, and senescence-associated secretory phenotype (SASP) converge to mediate age-related oocyte decline in preclinical models, with correlative human evidence supporting these observations. In preclinical models, these pathways have been associated with impaired oocyte quality through distinct mechanisms: spindle disruption and chromosome misalignment (TNF-α, IL-6), mitochondrial dysfunction and ATP depletion (NLRP3 activation, ROS), lipid peroxidation-induced membrane damage (ferroptosis), and impaired developmental competence manifesting as reduced fertilization and blastocyst formation rates (chronic inflammation); human evidence remains largely correlative. Emerging immunomodulatory strategies for fertility preservation are critically evaluated. This review conceptualizes oocyte quality as a property of immune-endocrine-stromal interactions and proposes microenvironment-aware models of female reproductive competence, while explicitly grading the strength of the underlying evidence.
Related
- Integrative follicular fluid biomarkers for oocyte competence and IVF outcomes: from molecular networks to multianalyte panels
- Immune-stimulatory cytokine IL-18 induces inflammatory senescence and impairs stem cell-mediated experimental skeletal regeneration
- Integrative analysis of Smart-seq2 and DIA proteomics reveals dynamic formation of the Balbiani body during oocyte development in leopard coral grouper (Plectropomus leopardus)
- DNA damage response as a driver of PD-L1 expression in cellular senescence: implications for immune evasion and immunosenescence
- Development of Active Spitting Competence in Children: A Clinical Perspective for Paediatric Dental Prevention
BibTeX
@article{jiang2026immune,
title = {{Immune architecture of oocyte competence: from development to senescence}},
author = {Man-Xi Jiang and Yan Zhu and Huai L. Feng},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1968598},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1968598/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Immune architecture of oocyte competence: from development to senescence
AU - Man-Xi Jiang
AU - Yan Zhu
AU - Huai L. Feng
PY - 2026
DA - 2026/10/20
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1968598
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1968598/full
AB - The mammalian oocyte does not develop in isolation. Throughout its protracted life history, from primordial germ cell specification to ovulation, the female gamete develops within a dynamic immune microenvironment that both supports and monitors its development. This review synthesizes current knowledge on the immunobiological mechanisms governing oocyte quality, with particular emphasis on how immune cells, cytokines, and inflammatory signaling pathways shape oocyte developmental competence across the reproductive lifespan. We examine the prenatal origins of ovarian immune colonization, the functional roles of tissue-resident macrophages, dendritic cells, and T lymphocytes in follicular dynamics, and the molecular pathways through which immune signals influence meiotic fidelity and mitochondrial function. The concept of the ovarian immune microenvironment as a critical determinant of oocyte quality is developed, integrating evidence from physiological ovarian aging and pathological conditions including primary premature ovarian insufficiency (POI). We further explore how immune checkpoint pathways, inflammasome activation, and senescence-associated secretory phenotype (SASP) converge to mediate age-related oocyte decline in preclinical models, with correlative human evidence supporting these observations. In preclinical models, these pathways have been associated with impaired oocyte quality through distinct mechanisms: spindle disruption and chromosome misalignment (TNF-α, IL-6), mitochondrial dysfunction and ATP depletion (NLRP3 activation, ROS), lipid peroxidation-induced membrane damage (ferroptosis), and impaired developmental competence manifesting as reduced fertilization and blastocyst formation rates (chronic inflammation); human evidence remains largely correlative. Emerging immunomodulatory strategies for fertility preservation are critically evaluated. This review conceptualizes oocyte quality as a property of immune-endocrine-stromal interactions and proposes microenvironment-aware models of female reproductive competence, while explicitly grading the strength of the underlying evidence.
SN - 1664-3224
ER -